Multicentre Study with Viloxazine (Vivalan®) in Depressed Patients
- 1 July 1980
- journal article
- clinical trial
- Published by S. Karger AG in International Pharmacopsychiatry
- Vol. 15 (4) , 228-239
- https://doi.org/10.1159/000468442
Abstract
Viloxazine at doses of 150-300 mg daily for 1 month produced significant and rapid responses (after 3 days) in this multicentre study involving 115 inpatients with moderate to severe depressive illness. Many had proved resistant to previous antidepressive treatment. Side effects were not a major problem of therapy with viloxazine.Keywords
This publication has 0 references indexed in Scilit: